You make some very good points.   It would seem that the pps history is hurting us now, even if Swartz is done or reduced the selling significantly.  The company must do something extraodinary to get the fence-sitters to buy PTSC stock.  Obviously selling licenses, no matter how much money they bring in, does not seem to do the trick.  M&A might, but is there sufficient funding and expertise to have any M&A pay off with significantly increased pps near-term?  If neither of the above will pull the pps up to where it should be, perhaps a special dividend might.  I never thought the divys were a good use of funds in the past, but PTSC needs to do something extraordinary to move the pps.  Perhaps they could they offer to buy back a percentage of everyone's holdings at a premium price?  Say 10% of holdings at $1.00.  It would cost PTSC about 40 mil.  A nice reward for patient shareholders, reduce outstanding by 40 mil and increase the value of treasury shares.  That would certainly kick-start the pps.  Opty